Research keywords (5)：
次世代シークエンス解析
, 消化器内視鏡
, pancreatic cancer
, 膵がん
, 消化器内科学
Research theme for competitive and other funds (5)：
2018 - 2021 High sensitive and comprehensive liquid biopsy by digital NGS
2015 - 2018 Next-generation sequencing of pancreatic juice to diagnose malignant intraductal papillary mucinous tumor
2013 - 2015 Diagnosing pancreatic diseases and predicting therapeutic efficacy by using next generation sequencing
pancreatic cancer
膵がん診療
Papers (58)：
Dai Yoshimura, Mitsuharu Fukasawa, Yoshioki Yoda, Masahiko Ohtaka, Tadao Ooka, Shinichi Takano, Satoshi Kawakami, Yoshimitsu Fukasawa, Natsuhiko Kuratomi, Shota Harai, et al. A Simple Clinical Scoring System to Determine the Risk of Pancreatic Cancer in the General Population. Diagnostics (Basel, Switzerland). 2024. 14. 6
Hitomi Takada, Koji Yamashita, Leona Osawa, Yasuyuki Komiyama, Natsuko Nakakuki, Masaru Muraoka, Yuichiro Suzuki, Mitsuaki Sato, Shinichi Takano, Mitsuharu Fukasawa, et al. Impact of renal function on the prognosis of patients receiving Atezolizumab / Bevacizumab combination therapy and Lenvatinib monotherapy for unresectable hepatocellular carcinoma. Oncology. 2023
Yuichiro Suzuki, Shinya Maekawa, Kohji Yamashita, Leona Osawa, Yasuyuki Komiyama, Natsuko Nakakuki, Hitomi Takada, Masaru Muraoka, Mitsuaki Sato, Shinichi Takano, et al. Effect of a combination of pemafibrate and a mild low-carbohydrate diet on obese and non-obese patients with metabolic-associated fatty liver disease. Journal of Gastroenterology and Hepatology. 2023
Satoshi Kawakami, Shinichi Takano, Mitsuharu Fukasawa, Hiroko Shindo, Ei Takahashi, Yoshimitsu Fukasawa, Hiroshi Hayakawa, Natsuhiko Kuratomi, Makoto Kadokura, Naohiro Hosomura, et al. Stepwise correlation of TP53 mutations from pancreaticobiliary maljunction to gallbladder carcinoma: a retrospective study. BMC Cancer. 2021. 21. 1
Masaru Muraoka, Shinya Maekawa, Ryo Katoh, Yasuyuki Komiyama, Natsuko Nakakuki, Hitomi Takada, Shuya Matsuda, Yuichiro Suzuki, Mitsuaki Sato, Akihisa Tatsumi, et al. Usefulness of Cell-Free Human Telomerase Reverse Transcriptase Mutant DNA Quantification in Blood for Predicting Hepatocellular Carcinoma Treatment Efficacy. Hepatology Communications. 2021. 5. 11. 1927-1938
